lobbying_filings_raw: 54a54086-f2a6-44a7-9a0a-d375a1a74d22

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API. Sortable columns (indexed): filing_type, client_name, filing_year, client_state, registrant_state, registrant_house_id, registrant_id. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
54a54086-f2a6-44a7-9a0a-d375a1a74d22 Q1 401104645 CEPI-U.S. 202185 CEPI-U.S. 2022 first_quarter 2022-04-18T16:40:46-04:00 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/54a54086-f2a6-44a7-9a0a-d375a1a74d22/", "filing_uuid": "54a54086-f2a6-44a7-9a0a-d375a1a74d22", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2022, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/54a54086-f2a6-44a7-9a0a-d375a1a74d22/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "50000.00", "expenses_method": "A", "expenses_method_display": "A", "posted_by_name": "Daniel Skallman", "dt_posted": "2022-04-18T16:40:46-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1901 Pennsylvania Ave, NW", "registrant_address_2": "Suite 1003", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20006", "registrant": {"id": 401104645, "url": "https://lda.senate.gov/api/v1/registrants/401104645/", "house_registrant_id": null, "name": "CEPI-U.S.", "description": "Advocacy and education on behalf of CEPI Norway", "address_1": "1901 Pennsylvania Ave, NW", "address_2": "Suite 1003", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20006", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "DANIEL SKALLMAN", "contact_telephone": "+1 202-809-6763", "dt_updated": "2026-01-20T12:01:39.409728-05:00"}, "client": {"id": 202185, "url": "https://lda.senate.gov/api/v1/clients/202185/", "client_id": 12, "name": "CEPI-U.S.", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2020-05-24"}, "lobbying_activities": [{"general_issue_code": "FOR", "general_issue_code_display": "Foreign Relations", "description": "Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations House Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023 Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023", "foreign_entity_issues": "The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.", "lobbyists": [{"lobbyist": {"id": 112566, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": null, "last_name": "SKALLMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 39, "name": "State, Dept of (DOS)"}, {"id": 196, "name": "U.S. Agency for International Development (USAID)"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations House Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023 Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2023", "foreign_entity_issues": "The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.", "lobbyists": [{"lobbyist": {"id": 112566, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": null, "last_name": "SKALLMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 39, "name": "State, Dept of (DOS)"}, {"id": 196, "name": "U.S. Agency for International Development (USAID)"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations S. 2640, Disease X Act, general support for legislation S.3799, PREVENT Pandemics Act, Titles 3,4 and 5, provisions related to vaccine research and development House Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act, FY2023 Senate Department of Labor, Health and Human Services, Education and Related Agencies Appropriations Act, FY2023", "foreign_entity_issues": "The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.", "lobbyists": [{"lobbyist": {"id": 112566, "prefix": null, "prefix_display": null, "first_name": "DANIEL", "nickname": null, "middle_name": null, "last_name": "SKALLMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 39, "name": "State, Dept of (DOS)"}, {"id": 196, "name": "U.S. Agency for International Development (USAID)"}, {"id": 12, "name": "White House Office"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US   DC DC US US   0 0           50000.0

Links from other tables